Skip to Content
Upcoming Webinar

Resource for the Clinical Management of Neuroendocrine Tumors

Date: April 29, 2025 | 2:00 PM

 

Join Amanda Cass, PharmD, BCPS, BCOP (Vanderbilt University Medical Center), for a focused review of cabozantinib in the treatment of neuroendocrine tumors (NETs).

This session will review:

  • Efficacy and safety data

  • Strategies for monitoring and managing adverse reactions

  • Patient education and treatment management tips

  • Available support resources for providers, patients, and caregivers

 

See full prescribing information for cabozantinib here.

If you have any questions or would like to request the meeting invite, contact Jonathan Rivera.

 

Login

Sponsored by

Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future